Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 15.9
Key Takeaways
Risk factor
Strong trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very weak growth
Data is available to registered users only
Data is available to registered users only
About
Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, and marketing of vaccines and biological products in China. The company was founded in 2009 and is based in Chongqing, China.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA
Data is available to registered users only
Target Price
The average target price of 300122.SZ is 28 and suggests 79% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Data is available to registered users only
